powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1821227273
Helen Shum
Hematology-Oncology
New Hyde Park,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
1,055
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
36
Brand share
54.6%
Top prescribed drugs
Anastrozole
134 claims
Darbepoetin Alfa In Polysorbat
110 claims
Fosnetupitant/Palonosetron
65 claims
Apixaban
53 claims
Letrozole
49 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
15.8
Cost
75.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$129
Payment records
1
By payment type
Food and Beverage
$129
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,273
Unique beneficiaries
—
Total services
38,929
Distinct HCPCS
63
Medicare payment
$404K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).